These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34470587)

  • 1. LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.
    Geng S; Tu S; Fu W; Wang J; Bai Z
    Cell Cycle; 2021 Oct; 20(19):1988-1998. PubMed ID: 34470587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
    Peng BH; Ji YF; Qiu XJ
    J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
    Ma X; Ren H; Zhang Y; Wang B; Ma H
    Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 6. LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p.
    Liu L; Dai A; Zhang Z; Ning M; Han D; Li L; Li Z
    Aging (Albany NY); 2021 Sep; 13(17):21191-21201. PubMed ID: 34496348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PITPNA-AS1 Inhibits Cell Proliferation and Migration in Ovarian Cancer by Regulating the MIR-223-3p/RHOB Axis.
    Zhang F; Zhang M; Chen Z; Yu B; He X; Luo Y; Ai F; Hu W
    Rev Invest Clin; 2024 May; 76(2):103-115. PubMed ID: 38753591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA NCK1-AS1 Aggravates Hepatocellular Carcinoma by the miR-22-3p/YARS Axis to Activate PI3K/AKT Signaling.
    Zhou W; Wang J; Zhang J; Wang Y; Jiang L; Guo T; Luo B; Xu Q; Huang Y
    J Gastrointestin Liver Dis; 2022 Mar; 31(1):48-59. PubMed ID: 35306563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA PITPNA-AS1 promotes cervical cancer progression through regulating the cell cycle and apoptosis by targeting the miR-876-5p/c-MET axis.
    Guo Q; Li L; Bo Q; Chen L; Sun L; Shi H
    Biomed Pharmacother; 2020 Aug; 128():110072. PubMed ID: 32460193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p.
    Hu C; Li S; Fu X; Zhao X; Peng J
    Cytokine; 2023 Feb; 162():156105. PubMed ID: 36527891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway.
    Zhang JY; Yang Z; Fang K; Shi ZL; Ren DH; Sun J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2647-2658. PubMed ID: 32196615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.
    Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q
    Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway.
    Wang Z; Han Y; Li Q; Wang B; Ma J
    Brain Behav; 2021 Oct; 11(10):e2321. PubMed ID: 34536977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncUBE2R2-AS1 acts as a microRNA sponge of miR-302b to promote HCC progression via activation EGFR-PI3K-AKT signaling pathway.
    Wu Z; Wei ZH; Chen SH
    Cell Cycle; 2020 Oct; 19(19):2426-2435. PubMed ID: 32835579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA WEE2-AS1 Plays an Oncogenic Role in Glioblastoma by Functioning as a Molecular Sponge for MicroRNA-520f-3p.
    Lin H; Zuo D; He J; Ji T; Wang J; Jiang T
    Oncol Res; 2021 Mar; 28(6):591-603. PubMed ID: 32838835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA FEZF1-AS1 aggravates cell proliferation and migration in glioblastoma.
    Zhou C; Jiang X; Liang A; Zhu R; Yang Y; Zhong L; Wan D
    Neurosci Lett; 2021 Nov; 764():136245. PubMed ID: 34530115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AFAP1-AS1 Promotes Proliferation of Pituitary Adenoma Cells through miR-103a-3p to Activate PI3K/AKT Signaling Pathway.
    Tang H; Zhu D; Zhang G; Luo X; Xie W
    World Neurosurg; 2019 Oct; 130():e888-e898. PubMed ID: 31299308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
    Hussain SA; Venkatesh T
    Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
    Liu HT; Ma RR; Lv BB; Zhang H; Shi DB; Guo XY; Zhang GH; Gao P
    Br J Cancer; 2020 Jun; 122(12):1825-1836. PubMed ID: 32336754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.